研究方向：糖尿病早期短程胰島素強化治療； 主要教育和工作經歷： 工作經歷： 2008.7-2012.12 中山大學附屬第一醫院內分泌科住院醫師 2013.1-2019.2中山大學附屬第一醫院內分泌科主治醫師 2019.3至今 中山大學附屬第一醫院內分泌科副主任醫師 教育經歷 2001.9-2008.6 中山大學中山醫學院七年制碩士 2012.9-2015.5 中山大學臨床醫學博士 2013.11-2014.10 瑞典隆德大學訪問學者 社會兼職： 廣東省醫師協會內分泌學分會委員 廣東省健康管理學會代謝與內分泌專業委員會常委 Diabetes care中文版編委 論著： 1.Liu L, Ke W, Wan X, Zhang P, Cao X, Deng W, Li Y. Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission. Diabetes Res Clin Pract. 2015. 108(2): 250-7. 2.Liu L, Omar B, Marchetti P, Ahren B. Dipeptidyl peptidase-4 (DPP-4): Localization and activity in human and rodent islets. Biochem Biophys Res Commun. 2014. 453(3): 398-404. 3.Ke W, Liu L, Liu J, Chen A, Deng W, Zhang P, Cao X, Liao Z, Xiao H, Liu J, Li Y. Effects of Liraglutide Combined with Short-Term Continuous Subctaneous Insulin Infusion on Glycemic Control and Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Pilot Study. J Diabetes Res. 2016. 2016: 6839735. 4.Liu L, Yang S, Liu J, Li H, Liu J, Cao X, Xiao H, Li Y. Fasting Plasma Glucose Indicates Reversibility of the Acute Insulin Response after Short-Term Intensive Insulin Therapy in Patients with Various Duration of Type 2 Diabetes. J Diabetes Res. 2018. 2018: 9423965. 5.Liu L, Wan X, Liu J, Huang Z, Cao X, Li Y. Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy. Diabetes Technol Ther. 2012. 14(9): 756-61. 6.Liu L, Liu J, Xu L, Ke W, Wan X, Li H, He X, Wang L, Cao X, Xiao H, Li Y. Lower mean blood glucose during short-term intensive insulin therapy is associated with long-term glycemic remission in patients with newly diagnosed type 2 diabetes: Evidence-based recommendations for standardization. J Diabetes Investig. 2018. 9(4): 908-916. 7.劉烈華. 基礎胰島素聯合口服降糖藥控糖不佳時的治療選擇. 糖尿病天地. 2016. 10(09): 419-421. 8.劉烈華, 李延兵. 細節決定成敗—論新診斷2...

從事內分泌及代謝病臨床及科研十余年，醫療專長為糖尿病及其并發癥的規范化診治，尤擅新診斷患者或口服藥失效患者短程強化治療誘導方案簡化。對于甲狀腺功能亢進/減退、甲狀腺結節、甲狀腺炎、腎上腺及垂體下丘腦疾病亦有較豐富的臨床經驗。